Alexandra Bernal: Uncovering the Anticoagulant Role of Factor V in Hemophilia A
Alexandra Bernal, Co-President / Mental Health Advocate at Morgan’s Message, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
“I’m excited to share that our research has been published in Blood!
Our paper, ‘Factor V is an anticoagulant of the extrinsic pathway of coagulation and modifier of thrombin generation in hemophilia A,’ explores an unrecognized anticoagulant role of factor V and its effects on thrombin generation in hemophilia A.
Through the Graduate Experience for Multicultural Students (GEMS) in summer 2024, I had the opportunity to contribute to this work by running calibrated automated thrombography (CAT) experiments, varying different factors to study thrombin generation.
Having the chance to contribute to research investigating the mechanisms underlying coagulation in hemophilia has been an incredibly valuable experience, and one that has strengthened my interest in incorporating biomedical research into my future practice of medicine.
I am beyond grateful to everyone who made this possible, especially Dr. Keith Neeves and Dr. Megan Jewell, as well as everyone in the Neeves lab, for the invaluable mentorship and support throughout the research process.
It’s so rewarding to see this work published in Blood, and this is an experience I will definitely carry with me throughout my journey in medicine.”
Title: Factor V is an anticoagulant of the extrinsic pathway of coagulation and modifier of thrombin generation in hemophilia A
Authors: Megan Jewell, Christine H. Baird, Dianne Thornhill, Zaina Ashour, Alexandra Riley Bernal, Julie Peterson, Rachel Blomberg, Chelsea M Magin, Alan E Mast, Marilyn J. Manco-Johnson, Suzanne Sindi, Aaron L Fogelson, Karin Leiderman, Shekhar Kumar, Dougald M Monroe, Keith B Neeves
Stay updated with Hemostasis Today.
-
Sep 1, 2026, 06:14Paolo Albino Ferrari: AnemiaScore for Cancer-Related Anemia Management
-
Sep 1, 2026, 04:27Ruth Fein: The Patient Impact of Transfusion Dependence in Myelofibrosis
-
Sep 1, 2026, 02:41Richard Buka: Win a Trip to ASH or ISTH 2027
-
Sep 1, 2026, 02:38Christian’s Journey to Stability on Avatrombopag – ITP Support Association
-
Sep 1, 2026, 02:35Alexis Guédon: Is IL-6 Pathway Inhibition Reduce Cardiovascular Risk in Giant Cell Arteritis?
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding